PrognomiQ Inc
Transform healthcare and early disease detection through the power of multi-omics data.
44 employees · est. 2020 · San Mateo, United States
Seer
Empowering scientists through unbiased, deep, rapid proteomics at scale
151 employees · est. 2017 · Redwood City, United States
Seer is the older company (2020 vs 2017); Seer is the larger of the two.
Side-by-Side Comparison
| Metric | PrognomiQ Inc | Seer |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2017 older |
| Headquarters | ||
| Headquarters | San Mateo, United States | Redwood City, United States |
| Employees | ||
| Employees | 44 | 151 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | Unknown | IPO |
| Total Funding | ||
| Total Funding | $145.00M | $344.50M |
| Funding Rounds | ||
| Funding Rounds | 6 | 7 |
| Services | ||
| Services | Development of transformative test products, Proprietary proteomic data generation, Integration of proteomic, genomic, and metabolomic data, Multi-omics platform development, Healthcare product innovation | Proteograph Product Suite, Seer Technology Access Center, Proteomics Research Projects, Seer Service Provider Solutions, AI-Driven Multi-Cancer Screening |
| Target Customers | ||
| Target Customers | Healthcare providers, Pharmaceutical companies, Research institutions, Biotechnology firms, Clinical laboratories | Research Scientists, Biotechnology Companies, Academic Institutions, Healthcare Providers, Pharmaceutical Companies |
| Taxonomy | ||
| Taxonomy | Multi-omics Data, Proteomics, Genomics, Metabolomics, Early Disease Detection, Cancer Detection, Disease Treatment, Proteograph Technology, Life Science Tools, Molecular Information, Clinical Diagnostics, Disease Insights, Molecular Diagnostics | Proteomics, Deep Proteomics, Unbiased Proteomics, Large-scale Studies, Proteomic Mass Spectrometry, Biomarker Discovery, Scientific Tools, Life Sciences, Multiomics, Diagnostics Solutions, Genomics-proteomics Integration, Technology Innovation, Biological Insights, Health And Disease Biology, Protein Diversity Analysis |
| Website | ||
| Website | prognomiq.com | seer.bio |
About PrognomiQ Inc
PrognomiQ Inc aims to revolutionize healthcare and early disease detection through its pioneering use of multi-omics data. Founded in 2020 and headquartered in the United States, PrognomiQ's approach focuses on generating highly accurate proteomic information swiftly and at scale. By integrating thi...
About Seer
Seer, founded in 2017, is at the forefront of the Biotechnology industry, with a mission encapsulated by its slogan: "Empowering scientists through unbiased, deep, rapid proteomics at scale." This innovative company is pioneering solutions to bridge the gap in proteomics technology that has historic...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at PrognomiQ Inc and Seer — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at PrognomiQ Inc and Seer — by email.
Frequently Asked Questions
Compare PrognomiQ Inc with someone else
Start typing a company name or domain.